- Home
- NRO vs CBUS Comparison
NRO vs CBUS Comparison
Compare NRO & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRO | CBUS |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.6M | 69.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | NRO | CBUS |
|---|---|---|
| Price | $3.02 | $1.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 239.4K | 172.4K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 11.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.51 | $1.09 |
| 52 Week High | $3.45 | $3.40 |
Technical Indicators
Market Signals| Indicator | NRO | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 54.23 |
| Support Level | $2.91 | $1.60 |
| Resistance Level | $3.06 | $1.77 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 75.00 | 45.45 |
Price Performance
Historical ComparisonAbout NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.